Collaborating with Patient Advocacy Groups to Educate Physicians, Patients and Thought Leaders
"Collaborating with Patient Advocacy Groups to Educate the Marketplace" is a 125-page report that identifies successful tactics and strategies for working with patient advocacy groups and managing relationships.
This benchmarking study identifies valuable practices in starting and maintaining collaborative relationships with patient advocacy groups. The research also examines ideal structures and skill sets for pharma groups that deal with advocacy groups. In addition, the study shares emerging trends and challenges in patient advocacy.
Fifty-eight advocacy leaders from 43 companies such as Abbott, Wyeth, Genentech, Novartis, Bayer, Amgen, Astellas, Takeda, Bristol-Myers Squibb and J&J shared their practices and insights into advocacy group collaborations. More than a dozen organizations participated in deep-dive interviews to provide actionable insights into working with the advocacy world.
Key topics of this report include:
Executives, directors and managers at device, pharmaceutical and biotech organizations who work in patient advocacy functions can use this research to compare their group's approaches and tactics for advocacy group interactions with those of leading organizations.
To learn more about this research project, download a complimentary report summary at: http://www3.best-in-class.com/rr1006.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.
-- Understanding the Advocacy Landscape -- Managing Advocacy Relationships -- Managing Relationships with Hostile Groups -- Structuring High Performance Biopharma Advocacy Groups -- Using New Technologies -- Current Trends and Future Directions
SOURCE Best Practices, LLC
You May Also Like